B H Rovin

Author PubWeight™ 18.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lymphocytes produce IL-1beta in response to Fcgamma receptor cross-linking: effects on parenchymal cell IL-8 release. J Immunol 1998 1.67
2 The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus 2010 1.21
3 Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int 2007 1.18
4 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol 2012 1.10
5 Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res 2009 1.03
6 Renoprotection: one or many therapies? Kidney Int 2001 0.96
7 Fc(gamma) receptor cross-linking induces peripheral blood mononuclear cell monocyte chemoattractant protein-1 expression: role of lymphocyte Fc(gamma)RIII. J Immunol 1997 0.95
8 Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diabetes Obes Metab 2006 0.94
9 Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus 2011 0.92
10 Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare. Clin Exp Immunol 2006 0.92
11 A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma. Biochem Biophys Res Commun 2001 0.88
12 Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1. J Diabetes Res 2013 0.87
13 Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 2012 0.85
14 Interleukin-1beta induction of mitogen-activated protein kinases in human mesangial cells. Role of oxidation. J Biol Chem 1997 0.83
15 Of mice and men: the relevance of the mouse to the study of human SLE. Immunol Res 2001 0.83
16 Macrophage-specific chemotactic lipid release by in vivo streptozocin-administered mouse islets. Diabetes 1991 0.81
17 Cytochrome P450 polymorphisms and the response of lupus nephritis to cyclophosphamide therapy. Clin Nephrol 2011 0.79
18 Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells. Kidney Int 1994 0.76
19 Beyond a glomerulocentric view of inflammation. Kidney Int 2001 0.75